ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

KUCHING: Asean must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV patients in their respective countries, says Datuk Lukanisman Awang Sauni.

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

KUCHING: Asean member states must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV ...

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Findings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...

Researchers from Instituto de Investigación Sanitaria Hospital Universitario de La Princesa and collaborators have developed nanoparticles loaded with poly(I:C) and used them to prime monocyte-derived ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.